Biotech Startups

N2TP builds autonomous AI systems with formal mathematical verification for life science R&D, aiming to make AI-driven hypotheses and experiments reproducible and trustworthy. Its platform powers applications including SmartDoseAI for model-informed precision dosing of narrow-therapeutic-window drugs and the LynxDetect programmable biosensor for point-of-care diagnostics.

1 investor

n6 is a genomics technology company that develops methods and tools for molecular R&D and genomics research. The company serves researchers and genomics labs.

1 investor

Nabsys develops genome mapping technology for genomic structural variant analysis, enabling precision and cost-effectiveness in this field. The company serves research and clinical customers globally.

1 investor

Based on the page listing "Ophthalmic Pharmaceutical Consultant" and "Chief Clinical Officer" roles, Nacuity appears to be a pharmaceutical company focused on ophthalmology (eye care), though the page provides insufficient detail to confirm products, customer base, or market focus.

1 investor

Nàdarra Ventures is a Canadian venture capital fund investing in early-stage companies developing sustainable solutions in agriculture, food, and materials through biotechnology and science-driven innovation.

1 investor

NADMED offers laboratory kits and analytical services for quantifying NAD and glutathione metabolites in research and diagnostic applications. The company provides CE-marked diagnostic kits, research-use-only kits, and custom quantification services for researchers and labs studying redox metabolism.

1 investor

Naegis Pharmaceuticals is a drug discovery and development company creating first-in-class small-molecule treatments for serious ophthalmic and inflammatory diseases. Its work targets inflammatory mechanisms, including leukotriene pathways, to develop new therapies for eye diseases.

1 investor

Nanil Therapeutics develops AI-native discovery platforms for CNS-targeting therapeutic modalities, focusing on RNA-based approaches for neurodegenerative diseases like tauopathies and Alzheimer's. The company integrates quantum computing, generative AI, and molecular modeling to design and optimize mRNA therapeutics and identify blood-brain barrier-penetrant biologics.

1 investor

Nano Discovery Inc. develops, manufactures and sells the D2Dx immunity test, a one-minute blood test that quantitatively assesses the immune health of livestock (cattle, sheep, goats, poultry, swine), companion animals (dogs and cats), and fish and shellfish for farmers, producers and veterinarians. It also supplies its products for human and non-human primate research applications such as drug and vaccine development.

1 investor

NanoBio Designs develops nanotechnology-based assays and detection devices that use microparticle pairing to visibly identify target DNA sequences and genetic markers in grain samples such as soybeans. The company serves the agriculture and grain-processing industry, with operations in Indiana and Iowa.

1 investor

NanoDx develops point-of-care diagnostic devices using nanowire biosensor technology to deliver rapid test results at patient locations, targeting unmet clinical needs globally.

1 investor

NANOEGG is a pharmaceutical and cosmetics development company that conducts drug research and development, produces non-pharmaceutical health products and cosmetics, and sells pharmaceutical bases and cosmetic raw materials. The company serves pharmaceutical manufacturers, cosmetics brands, and health product developers in Japan.

1 investor

Nanoflexion is a medtech spin-off developing an electrospun nanofiber surgical patch that acts as a biodegradable, biocompatible barrier to prevent anastomotic leakage and postoperative adhesions after colorectal and gastrointestinal surgery. The patch is applied during surgery without extra tools and can serve as a local drug delivery system, targeting surgical care in Europe.

1 investor

US-based vertically integrated biologics and disc replacement manufacturer, acquired by KIC in 2018.

1 investor

NanoGhost develops a drug targeting platform called Nano-Ghosts (NGs), nanovesicles made from the cell membrane of mesenchymal stem cells that target cancer and inflammation sites and can carry various therapeutic loads. The biotech company's technology originates from research at the Technion – Israel Institute of Technology.

1 investor

NanoGrow Biotech develops biological therapies based on a single-domain antibody (nanobody) platform, combined with various formulations such as topical, inhaled, injectable, and oral delivery. Its targeted therapies address conditions including psoriasis, asthma, inflammatory bowel disease, and melanoma.

1 investor

NanoGuard Technologies develops sterilization technologies for medical applications.

1 investor

Nano Imaging Services is a US-based contract research organization (CRO) with in-house cryo-EM microscopes, providing protein production and cryo-electron microscopy services. It supports structure-based drug design and nanoparticle characterization for drug discovery clients.

1 investor

NanoInGreen uses microbial fermentation with a platform of over 150 microorganism strains as biofactories to produce bioavailable, GRAS-status, GMO-free ingredients for the food industry, such as a natural food preservative and a highly absorbable iron mineral. It serves food companies looking to enhance formulations, replace existing ingredients, or develop new nutritional products.

1 investor

NanoJump develops portable technology for in-field extraction and purification of DNA/RNA, aiming to move genetic material extraction out of centralized labs. Its solutions support genome-based applications in disease prevention, precision medicine, and agricultural livestock productivity.

1 investor

Nanolive develops automated, label-free live cell imaging and analysis instruments with AI-powered digital assays for cell biology researchers. Its tools support noninvasive, quantitative study of cells for applications such as drug discovery, cell health profiling, and mitochondrial analysis.

1 investor

Nanological is a deep tech diagnostics company spun out of Spain's CSIC that develops a platform for ultrafast identification of pathogens directly from blood, using optomechanical sensing and AI without culturing or labeling. Its technology targets rapid sepsis detection to support early, pathogen-specific clinical treatment.

1 investor

Nanolumi is a science and technology company that develops nanomaterial-based innovations, operating internationally from a base in Singapore. Its areas of work include fuel integrity applications.

1 investor

Affordable diagnostic and monitoring platforms for health information. Private, San Diego, CA.

1 investor